Neurology, Pediatrics and the Center for Sleep Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA,
Curr Treat Options Neurol. 2012 Dec;14(6):630-49. doi: 10.1007/s11940-012-0199-0.
Dyssomnias are sleep disorders associated with complaints of insomnia or hypersomnia. The daytime sleepiness of narcolepsy is treated by a combination of planned daytime naps, regular exercise medications such as modafinil, or salts of methylphenidate, or amphetamine. Cataplexy that accompanies narcolepsy is treated with anticholinergic agents, selective serotonin reuptake inhibitors, or sodium oxybate. Children with neurodevelopmental disabilities such as autism have sleep initiation and maintenance difficulties on a multifactorial basis, with favorable response to melatonin in some patients. Childhood onset restless legs syndrome is often familial, associated with systemic iron deficiency, and responsive to iron supplementation and gabapentin. Parasomnias are episodic phenomena events which occur at the sleep -- wake transition or by intrusion on to sleep. Arousal parasomnias such as confusional arousals and sleep walking can sometimes be confused with seizures. A scheme for differentiating arousal parasomnias from nocturnal seizures is provided. Since arousal parasomnias are often triggered by sleep apnea, restless legs syndrome, or acid reflux, treatment measures directed specifically at these disorders often helps in resolution. Clonazepam provided in a low dose at bedtime can also alleviate sleep walking and confusional arousals. Obstructive sleep apnea affects about 2 percent of children. Adeno-tonsillar hypertrophy, cranio-facial anomalies, and obesity are common predisposing factors. Mild obstructive sleep apnea can be treated using a combination of nasal corticosteroids and a leukotriene antagonist. Moderate to severe obstructive sleep apnea are treated with adeno-tonsillectomy, positive airway pressure breathing devices, or weight reduction as indicated. This paper provides an overview of the topic, with an emphasis on management steps. Where possible, the level of evidence for treatment recommendations is indicated.
睡眠障碍是指与失眠或嗜睡等抱怨相关的睡眠紊乱。发作性睡病的日间嗜睡通过计划日间小睡、常规运动、莫达非尼或哌甲酯或苯丙胺等药物的组合来治疗。伴随发作性睡病的猝倒症用抗胆碱能药物、选择性 5-羟色胺再摄取抑制剂或羟丁酸钠治疗。具有神经发育障碍(如自闭症)的儿童在多因素基础上存在入睡和维持睡眠困难的问题,一些患者对褪黑素反应良好。儿童期起病的不安腿综合征常为家族性的,与系统性铁缺乏有关,对铁补充和加巴喷丁有反应。睡眠相关运动障碍是指在睡眠-觉醒转换时或睡眠中出现的阵发性现象。觉醒相关睡眠障碍,如意识模糊性觉醒和梦游,有时可能与癫痫发作混淆。提供了一种用于区分觉醒相关睡眠障碍和夜间癫痫发作的方案。由于觉醒相关睡眠障碍通常由睡眠呼吸暂停、不安腿综合征或胃酸反流触发,因此专门针对这些疾病的治疗措施通常有助于解决问题。在睡前以低剂量给予氯硝西泮也可以缓解梦游和意识模糊性觉醒。阻塞性睡眠呼吸暂停影响约 2%的儿童。腺样体扁桃体肥大、颅面畸形和肥胖是常见的诱发因素。轻度阻塞性睡眠呼吸暂停可以通过鼻用皮质类固醇和白三烯拮抗剂的联合治疗来治疗。中度至重度阻塞性睡眠呼吸暂停则需要根据情况进行腺样体扁桃体切除术、气道正压通气设备或减肥治疗。本文对该主题进行了概述,重点介绍了管理步骤。在可能的情况下,还指出了治疗建议的证据水平。